1. Home
  2. SMLR vs EDD Comparison

SMLR vs EDD Comparison

Compare SMLR & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMLR
  • EDD
  • Stock Information
  • Founded
  • SMLR 2007
  • EDD 2007
  • Country
  • SMLR United States
  • EDD United States
  • Employees
  • SMLR N/A
  • EDD N/A
  • Industry
  • SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EDD Finance Companies
  • Sector
  • SMLR Health Care
  • EDD Finance
  • Exchange
  • SMLR Nasdaq
  • EDD Nasdaq
  • Market Cap
  • SMLR 289.5M
  • EDD 304.3M
  • IPO Year
  • SMLR 2014
  • EDD N/A
  • Fundamental
  • Price
  • SMLR $71.84
  • EDD $4.70
  • Analyst Decision
  • SMLR
  • EDD
  • Analyst Count
  • SMLR 0
  • EDD 0
  • Target Price
  • SMLR N/A
  • EDD N/A
  • AVG Volume (30 Days)
  • SMLR 1.1M
  • EDD 254.3K
  • Earning Date
  • SMLR 11-04-2024
  • EDD 01-01-0001
  • Dividend Yield
  • SMLR N/A
  • EDD 7.52%
  • EPS Growth
  • SMLR N/A
  • EDD N/A
  • EPS
  • SMLR 2.04
  • EDD N/A
  • Revenue
  • SMLR $58,938,000.00
  • EDD N/A
  • Revenue This Year
  • SMLR N/A
  • EDD N/A
  • Revenue Next Year
  • SMLR N/A
  • EDD N/A
  • P/E Ratio
  • SMLR $31.66
  • EDD N/A
  • Revenue Growth
  • SMLR N/A
  • EDD N/A
  • 52 Week Low
  • SMLR $20.88
  • EDD $4.22
  • 52 Week High
  • SMLR $79.45
  • EDD $4.95
  • Technical
  • Relative Strength Index (RSI)
  • SMLR 67.75
  • EDD 49.17
  • Support Level
  • SMLR $58.75
  • EDD $4.69
  • Resistance Level
  • SMLR $65.97
  • EDD $4.76
  • Average True Range (ATR)
  • SMLR 7.71
  • EDD 0.05
  • MACD
  • SMLR -0.05
  • EDD 0.01
  • Stochastic Oscillator
  • SMLR 72.28
  • EDD 62.50

About SMLR Semler Scientific Inc.

Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.

About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.

Share on Social Networks: